Monday, October 30, 2017 9:21:01 AM
TEMECULA, Calif., Oct. 30, 2017 (GLOBE NEWSWIRE) -- International Endeavors Corporation (OTC:IDVV) ("IEC") today announced updates on KUBBY Cryogenics, Inc., subsidiary partner of IEC, and biomedical cannabis research and development firm.
Kubby Cryogenics manufacturing division produces a unique biomedicine from the raw cannabis plant. This new class of medicine, the Kubby Cryogenics method, is the company’s own proprietary method capturing the vitality of the raw plant in its extraction process. This small batch, apothecary approach captures the live resins that have medical benefits for a number of ailments, including: cancer, inflammatory disease, epilepsy, brain injury, autism, Alzheimer’s, and more.
Currently research being done focuses on the medical value in specific strains that may be used in the company’s proprietary Cryogenic process, a broad-spectrum therapy. Kubby Cryogenics is working with genetic partners to secure several medicinal strains to patent for this use. Most people of all ages can potentially use Kubby Cryogenics because it’s naturally a non-psychoactive product.
“Our Cryogenic process appears to trigger the production of Adult Stem Cells, based on independent research on the Endocannabinoid system and the entourage effect,” said Steve Kubby, CEO and President of Kubby Cryogenics. According to a recent peer reviewed study, the endocannabinoid system directs cell fate specification of Neural Stem Cells in the Central Nervous System, which can lead to new cell generation in the brain and the periphery systems. (https://www.ncbi.nlm.nih.gov/pubmed/24076098 and 24256257)
Kubby Cryogenics is in the process of gathering information from its research and testimonials of patients. We plan to develop a website shortly that will focus on Kubby Cryogenics and its efforts.
Cryogenics Medical Uses
Cancer, Fibromyalgia, Arthritis, High Blood Pressure, Epilepsy, Brain Injury, Stroke, Inflammation, and PTSD.
Mr. Steve Kubby Bio
Steven Wynn "Steve" Kubby played a key role in the passage of California Proposition 215, a ballot initiative passed in 1996 to legalize medical marijuana. He is a well-known cancer patient of 36 years, who benefits his recovery through the use of non-psychoactive Cryogenics, a raw cannabis extract. Steve Kubby was formally Chairman and CEO of Cannabis Sativa Inc., traded under the symbol CBDS, and has authored 2 books on drug policy reform. Mr. Kubby's distinguished political career includes runs for Governor of California in 1998, and the 2008 Presidential primary race under the libertarian ticket.
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM